InClin

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-11-03

ROUNDS

as lead investor

LED ROUNDS · USD

$30M

across 1 round

LATEST ROUND

Series B · $30M · 2026-11-03

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Thryv Therapeutics Inc. A clinical-stage biotechnology company developing precision therapies for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.	Series B Verified against 3 sources	$30M	2026-11-03	[ LEAD ]